- Tomatis L, Aitio A, Day NE, Heseltine E, Kaldor J, Miller AB, et al. Cancer of the kidney: causes, occur-rence and control. IARC Sci Publ 1990; 100: 78–9.
- Engeland A, Haldorsen T, Tretli S, Bakulinen T, Horte LG, Luostarinen T, et al. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl 1993; 38: 90–5.
- Belldegrun A, deKemion JB In: Walsh PC, Retik AB, Vaughan Jr ED, Wein AJ, eds. Campbell's urology, 7th edn. Philadelphia PA: Saunders, 1998: 2283–326.
- Ritchie AW, Chisholm GD. Management of renal carcinoma—a questionnaire survey. Br J Urol 1983; 55: 591–4.
- Lang EK. Comparison of dynamic and conventional computed tomography, angiography and ultrasonogra-phy in the staging of renal cell carcinoma. Cancer 1984; 54: 2205–14.
- Brierly RD, Thomas PJ, Harrison NW, Fletcher MS, Nawrocki JD, Ashton-Key M. Evaluation of fine-needle aspiration cytology for renal masses. BJU Int 2000; 85: 14–8.
- Moore MJ, O'Sullivan B, Tannock IF. How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol 1988; 6: 1736–45.
- Bower M, Ma R, Savage P, Abel P, Waxman J. British urological surgery practice. 2. Renal, bladder and testis cancer. Br J Urol 1998; 81: 513–7.
- Yonover PM, Flanigan RC. Should radical nephrectomy be performed in the face of surgically incurable disease? Curr Opin Urol 2000; 10: 429–34.
- Ljungberg B, Landberg G, Alamdari Fl. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 2000; 34: 246–51.
- Mickisch GH, Garin A, van Poppel H, de Prijek L, Sylvester R. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358: 966–70.
- Dutcher JP. Immunotherapy: are we making a differ-ence? Curr Opin Urol 2000; 10: 435–9.
- Ljungberg B, Alamdari Fl, Rasmuson T, Roos G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999; 84: 405–11.
Status of pretreatment evaluation, treatment and follow‐up regimens for renal cell carcinoma in the Nordic countries
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.